Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 5/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | HSPB1 | P04792 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.42 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL427368 | 0.89 | ALDH1A1 (0.55) | TTRMEN1KMT2AALDH1A1HSPB1 | |
| SCHEMBL29821424 | 0.89 | ALDH1A1 (0.55) | TTRMEN1KMT2AALDH1A1HSPB1 | |
| SCHEMBL823705 | 0.86 | RECQL (0.56) | TTRMEN1KMT2AALDH1A1HSPB1 | |
| SCHEMBL30318004 | 0.86 | RECQL (0.56) | TTRMEN1KMT2AALDH1A1HSPB1 | |
| SCHEMBL18328831 | 0.85 | SMN1; SMN2 (0.40) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL13592911 | 0.85 | MEN1 (0.48) | TTRMEN1KMT2AALDH1A1HSPB1 | |
| SCHEMBL1322478 | 0.84 | TTR (0.52) | TTRMEN1KMT2AALDH1A1HSPB1 | |
| SCHEMBL1322476 | 0.84 | TTR (0.52) | TTRMEN1KMT2AALDH1A1HSPB1 | |
| SCHEMBL1220299 | 0.82 | ALDH1A1 (0.55) | TTRMEN1KMT2AALDH1A1HSPB1 | |
| SCHEMBL29379815 | 0.82 | ALDH1A1 (0.55) | TTRMEN1KMT2AALDH1A1HSPB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115466428-A | Bactericidal and acarid-removing pillow and preparation method thereof | 余亮 | 2022-12-13 | — | — | CN | claimed |
| CN-115466428-A | Bactericidal and acarid-removing pillow and preparation method thereof | 余亮 | 2022-12-13 | — | — | CN | disclosed |
| US-20080194673-A1 | Environment-Friendly Pollution-Proof Agent | SOONCHUNHYANG UNIVERSITY INDUSTRY ACADEMY COOPERATION FOUNDATION (KR) | 2008-08-14 | — | — | US | disclosed |
| US-20080071005-A1 | Environment-Friendly Pollution-Proof Agent | SOONCHUNHYANG UNIVERSITY INDUSTRY ACADEMY COOPERATION FOUNDATION (KR) | 2008-03-20 | — | — | US | disclosed |
| US-20080003288-A1 | Responsive microgel and methods related thereto | SUPRATEK PHARMA INC. (CA) | 2008-01-03 | — | — | US | disclosed |
| US-7204997-B2 | Responsive microgel and methods related thereto | SUPRATEK PHARMA INC. (CA) | 2007-04-17 | — | — | US | disclosed |
| EP-1478403-A1 | RESPONSIVE MICROGEL AND METHODS RELATED THERETO | SUPRATEK PHARMA, INC. (CA) | 2004-11-24 | — | — | EP | disclosed |
| US-20030152623-A1 | Responsive microgel and methods related thereto | SUPRATEK PHARMA INC. (CA) | 2003-08-14 | — | — | US | disclosed |
| WO-2003063909-A1 | RESPONSIVE MICROGEL AND METHODS RELATED THERETO | SUPRATEK PHARMA INC. (US) | 2003-08-07 | — | — | WO | disclosed |
| US-6491903-B1 | NARROW MOLECULAR WEIGHT DISTRIBUTION SHELL-CORE POLYMERS HAVING HYDROPHILIC, CROSSLINKED PERMEABLE SHELLS AND HYDROPHOBIC CORES, USED FOR REDUCING BLOOD CHOLESTEROL AND BILE ACID UPTAKE IN INTERSTINES; DRUG DELIVERY | WASHINGTON UNIVERSITY | 2002-12-10 | — | — | US | disclosed |
| US-6383500-B1 | Particles comprising amphiphilic copolymers, having a crosslinked shell domain and an interior core domain, useful for pharmaceutical and other applications | WASHINGTON UNIVERSITY | 2002-05-07 | — | — | US | disclosed |
| EP-0674325-A2 | Electrically insulating polymer composition and wire or cable using the same | Nippon Petrochemicals Co., Ltd. (JP) | 1995-09-27 | — | — | EP | disclosed |
| US-5304619-A | Containing nitrile or nitro polar groups; high voltage | NIPPON PETROCHEMICALS CO., LTD. (JP) | 1994-04-19 | — | — | US | disclosed |
| EP-0463402-A2 | Ethylene polymers or copolymers having improved insulating properties, compositions, and power cables made therefrom | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1992-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080194673-A1 | Environment-Friendly Pollution-Proof Agent | TST, TBCD, TBCA | TTR 519/4885MEN1 4753/4885KMT2A 2183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.